PGR and triple-negative breast carcinoma: Breast cancer metastasises to multiple sites, most frequently to the bones, lung, brain and liver, and patients with triple negative breast cancer, lacking expression of the oestrogen receptor (ER), the progesterone receptor (PR) and HER2, have fewer treatment options and a greater risk of metastasis (Garrido-Castro et al., 2019; Riggio et al., 2021).